4//SEC Filing
Jacobs John C 4
Accession 0001104659-24-039129
CIK 0001000694other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 6:11 PM ET
Size
8.4 KB
Accession
0001104659-24-039129
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Jacobs John C
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+500,000→ 500,000 totalExercise: $5.39From: 2025-03-01Exp: 2034-03-01→ Common Stock (500,000 underlying) - Award
Restricted Stock Units
2024-03-01+250,000→ 250,000 total→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the March 1, 2024 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 Grant Date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001820836
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 6:11 PM ET
- Size
- 8.4 KB